Evidence map›Paper›PMID 35270462›Full record

ReviewInternational journal of environmental research and public health2022

The Construct of Medical and Non-Medical Marijuana-Critical Review.

Andrzej Silczuk, Daria Smułek, Marcin Kołodziej, Julia Gujska

Open access · goldAbstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. A 2025 Nationwide Cross-Sectional Survey on Public Attitudes Toward the Legalization and Depenalization of Recreational Cannabis in Poland.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Exploring the Link Between Attention-Deficit Hyperactivity Disorder and Cannabis Use Disorders: A Review.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Andrzej SilczukDepartment of Public Health, Medical University of Warsaw, 02-091 Warszawa, Poland.
Daria SmułekThird Department of Psychiatry, Institute of Psychiatry and Neurology, 02-957 Warszawa, Poland.
Marcin KołodziejMasovian Specialized Health Center, 05-802 Pruscow, Poland.
Julia GujskaDepartment of Psychology, SWPS University of Social Sciences and Humanities, 03-815 Warszawa, Poland.
Institute of Psychiatry and Neurology · PLMedical University of Warsaw · PLUniwersytet SWPS · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rising popularity of medical marijuana and its potential therapeutic uses has resulted in passionate discussions that have mainly focused on its possible benefits and applications. Although the concept itself seems promising, the multitude of presented information has noticeable ramifications-terminological chaos being one. This work aimed to synthesize and critically analyze scientific evidence on the therapeutic uses of cannabinoids in the field of psychiatry. Emphasis was placed on the anxiolytic effects of cannabis constituents and their effects on post-traumatic stress disorder, anxiety disorders, schizophrenia spectrum, and other psychotic disorders. The review was carried out from an addictological perspective. A database search of interchangeably combined keywords resulted in the identification of subject-related records. The data were then analyzed in terms of relevance, contents, methodologies, and cited papers. The results were clear in supporting one common conclusion: while most findings provide support for beneficial applications of medical marijuana in psychiatry, no certain conclusions can be drawn until larger-scaled, more methodologically rigorous, and (preferably) controlled randomized trials verify these discoveries.

Indexed as

CannabinoidsCannabisMedical MarijuanaStress Disorders, Post-TraumaticAnxiety DisordersHumansCannabinoidsMedical MarijuanaanxietyanxiolyticcannabinoidsCBDmedical marijuanapsychiatrypsychosisPTSDTHCtreatment

Identifiers

PMID35270462
PMCPMC8910105
OpenAlexW4214576862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.